Virtual screening, docking, and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis

J Biomol Struct Dyn. 2016 Oct;34(10):2184-98. doi: 10.1080/07391102.2015.1110832. Epub 2016 Jan 11.

Abstract

In the present work, we propose to design drugs that target the enzyme dihydrofolate redutase (DHFR) as a means of a novel drug therapy against plague. Potential inhibitors of DHFR from Yersinia pestis (YpDHFR) were selected by virtual screening and subjected to docking, molecular dynamics (MD) simulations, and Poisson-Boltzmann surface area method, in order to evaluate their interactions in the active sites of YpDHFR and human DHFR (HssDHFR). The results suggested selectivity for three compounds that were further used to propose the structures of six new potential selective inhibitors for YpDHFR.

Keywords: Yersinia pestis; YpDHFR; docking; molecular dynamics; plague; selective inhibition; virtual screening.

MeSH terms

  • Binding Sites
  • Catalytic Domain
  • Drug Design*
  • Folic Acid Antagonists / chemistry*
  • Hydrogen Bonding
  • Ligands
  • Molecular Conformation
  • Molecular Docking Simulation*
  • Molecular Dynamics Simulation*
  • Protein Binding
  • Tetrahydrofolate Dehydrogenase / chemistry*
  • Yersinia pestis / enzymology*

Substances

  • Folic Acid Antagonists
  • Ligands
  • Tetrahydrofolate Dehydrogenase